by Mike and Colin | Oct 15, 2021 | M&A / Capital Raise, Macro
Canopy is paying $297.5M for the right to buy Wana 5 years after it is “Federally permissible”, and Cronos paid $110.4 million for the right to buy 10.5% of Pharmacann when legal. What exactly are they getting, why are they buying, and why is it smart for Wana and...
by Mike and Colin | Sep 21, 2021 | Data & Analysis, Macro
Michigan published the August 2021 data for their cannabis market, and we have organized an update on market share in the state; this article includes a monthly state data review for Michigan, complete with a working model of supply and pricing trends, inventory...
by Mike and Colin | Sep 8, 2021 | Comp Table, Data & Analysis, Macro
Average daily trading volumes for U.S. cannabis operators appear to be bottoming out at about $80 million per day, a level not seen since October 2020. Trading volumes have declined 75% since peaking in February. Despite the drop, the volume remains nearly triple the...
by Mike and Colin | Aug 30, 2021 | Data & Analysis, Macro
The weekly Florida review for Premium Members includes a working model with price checks of every operator’s flower, pre-roll, vape, edibles, and concentrate products, the weekly discounting trends, market share analysis, and all OMMU data. This particular review...
by Mike and Colin | Aug 18, 2021 | Comp Table, Data & Analysis, Macro
There is a disconnect between fundamental performance and stock performance for U.S. cannabis companies, resulting in compressing valuations for those operations. But multiples on 2022 are nearing past trough levels. Strong second quarter earnings have not yet driven...
by Mike and Colin | Aug 12, 2021 | Data & Analysis, Free, Macro
Despite being a top cannabis market in the United States, Michigan largely has been ignored by multistate operators because of the low barriers to entry for new licensees. However, with plenty of market growth and heavy fragmentation across the supply chain, the...
